Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Pharmacology›Antioxidants
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Antioxidants

Pharmacology · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed9 referencesApproximately 3 min read

Naturally occurring or synthetic substances that inhibit or retard oxidation reactions.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 3 complete abstracts (643 words), 9 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Anti-Oxidant; Anti Oxidant; Anti-Oxidants; Anti Oxidants; Antioxidant; Antioxidant Effect; Antioxidant Effects; Anti-Oxidant Effect.

Where it fits in the MeSH classification

Broader topics
Biological Factors; Molecular Mechanisms of Pharmacological Action; Protective Agents
Narrower topics
Free Radical Scavengers
See also
Pharmaceutic Aids; Oxidative Stress; Oxygen Radical Absorbance Capacity

Research landscape

PubMed indexes 206,435 records tagged with the MeSH heading “Antioxidants” (counts retrieved 2026-10-29). 72,708 of them (35.2%) were published from 2020 onward, and the busiest period so far is 2010-2019 with 74,323 records.

Reviews account for 25,191 records (12.2%) and meta-analyses for 856. Randomized controlled trials number 5,057 (2.4%) as a share of all records on the topic.

PubMed records by publication periodthrough 1999: 16,015 records; 2000-2009: 43,389 records; 2010-2019: 74,323 records; 2020 onward: 72,708 records16,015through 199943,3892000-200974,3232010-201972,7082020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 199916,015
2000-200943,389
2010-201974,323
2020 onward72,708
Share of records by publication typeReviews: 12.2 percent; Meta-analyses: 0.4 percent; Randomized controlled trials: 2.4 percentReviews12.2% (25,191)Meta-analyses0.4% (856)Randomized controlled trials2.4% (5,057)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 206,435 PubMed records
TypeRecordsShare
Reviews25,19112.2%
Meta-analyses8560.4%
Randomized controlled trials5,0572.4%

Method: PubMed query "Antioxidants"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in pharmacology

Drug evidence builds in layers: laboratory pharmacology describes how a compound acts, pharmacokinetic studies describe how the body handles it, and randomized trials test whether it helps and what harms it causes. Post-marketing surveillance and observational studies reveal rarer adverse effects but cannot prove causation. This page is educational and is not a recommendation to start, stop or change any medicine; decisions about treatment belong with a qualified clinician.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Drought modulates ozone stress through BVOCs, antioxidant defenses, and metabolic responses in a tropical tree
Anselmo-Moreira F, Claude A, do Nascimento A, da Costa BRB, Hurtado-Caceres I, Rocco M, et al.
2026Research article
Design not recorded in structured metadata
2cc by
PMID 42477286 · DOI · PMC13384984
Biochar-biostimulant combinations enhance nodulation, yield, and antioxidant defense in mungbean under reduced NPK fertilization
Amin M, Sani MNH, Rahman MM, Akter S, Mahabub MR, Mohsin SM, et al.
2026Research article
Design not recorded in structured metadata
1cc by
PMID 42533028 · DOI · PMC13424373
Anti-Inflammatory and Antioxidant Strategies in Epilepsy: From Molecular Mechanisms to Threshold Management
Trofimov A, Shcherbakova K, Schwarz A, Akbay B, Karapina O, Myrkhiyeva Z, et al.
2026Review article
Design not recorded in structured metadata
1cc by
PMID 42589265 · DOI · PMC13466846

Drought modulates ozone stress through BVOCs, antioxidant defenses, and metabolic responses in a tropical tree [1]

Research article Anselmo-Moreira F, Claude A, do Nascimento A, da Costa BRB, Hurtado-Caceres I, Rocco M, et al. · · 2026 · cited 2 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Main conclusionWater limitation attenuated ozone-induced oxidative stress in Eugenia uniflora, maintaining physiological stability and promoting targeted biogenic volatile organic compounds (BVOCs) and metabolic adjustments rather than large-scale disruption.
Closing excerpt
uniflora maintained physiological stability while adjusting volatile emissions and metabolic pathways under concurrent stress, providing new insights into the mechanisms governing drought-ozone interactions in tropical trees.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (276 words)

Main conclusionWater limitation attenuated ozone-induced oxidative stress in Eugenia uniflora, maintaining physiological stability and promoting targeted biogenic volatile organic compounds (BVOCs) and metabolic adjustments rather than large-scale disruption. Tropical forests are increasingly exposed to multiple environmental stressors, yet the combined effects of drought and ozone on native tropical tree species remain poorly understood. We investigated the individual and interactive effects of water limitation and ozone exposure on Eugenia uniflora saplings using an integrated physiological, biochemical, metabolomic, and biogenic volatile organic compound (BVOC) emission approach. Saplings were subjected to four treatments: control, drought, ozone fumigation, and combined drought-ozone. Drought was imposed by withholding irrigation for ten days, while ozone exposure (80-120 ppb) was applied for six days, reaching a cumulative AOT40 of 930.7 ppb h. Despite reductions in soil moisture, no significant changes were observed in leaf relative water content, gas exchange, or photosynthetic pigment, indicating high physiological resilience. Ozone exposure alone induced depletion of antioxidant pools, reducing ascorbate and glutathione concentrations, while redox ratios remained stable. BVOC emissions comprised 15 compounds across five chemical classes, dominated by oxygenated sesquiterpenes and sesquiterpenes. Although total emission rates did not differ among treatments, multivariate analyses revealed shifts in BVOC composition, including methyl salicylate and β-ocimene under water limitation and farnesane under combined stress. Metabolomic profiling revealed coordinated adjustments in sugars, amino acids, and oleanolic acid associated with ozone exposure. Notably, antioxidant depletion observed under ozone alone was not detected under combined stress, suggesting a non-additive interaction between water limitation and ozone. Overall, E. uniflora maintained physiological stability while adjusting volatile emissions and metabolic pathways under concurrent stress, providing new insights into the mechanisms governing drought-ozone interactions in tropical trees.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42477286 · DOI · PMC13384984

Biochar-biostimulant combinations enhance nodulation, yield, and antioxidant defense in mungbean under reduced NPK fertilization [2]

Research article Amin M, Sani MNH, Rahman MM, Akter S, Mahabub MR, Mohsin SM, et al. · · 2026 · cited 1 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Reducing mineral fertilizer inputs while maintaining crop productivity is a central challenge for sustainable grain legume production.
Closing excerpt
fluorescens supplementation as a promising strategy for sustaining mungbean productivity under reduced NPK input, warranting further field validation for broader applicability.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (193 words)

Reducing mineral fertilizer inputs while maintaining crop productivity is a central challenge for sustainable grain legume production. This study evaluated whether biochar-biostimulant combinations could improve mungbean (Vigna radiata L.) performance under reduced NPK fertilization. A polytunnel pot experiment was conducted using a completely randomized 2 × 4 factorial design with two NPK levels, 100% and 50% of the recommended dose, and four treatments: biochar alone, biochar + humic acid, biochar + Bacillus amyloliquefaciens, and biochar + Pseudomonas fluorescens. Biostimulant addition to biochar improved plant growth, pigment status, and antioxidant response, with the strongest responses observed under reduced NPK supply. Under 50% NPK, biochar + P. fluorescens increased grain yield by approximately 90% compared with biochar alone and maintained grain yield (4.00 g plant⁻¹) comparable to the 100% NPK biochar-only control (3.85 g plant⁻¹). It also enhanced nodulation, increased total chlorophyll by approximately 60%, and reduced malondialdehyde by approximately 50%. Grain weight was positively associated with nodule number and ascorbic acid content and negatively associated with H₂O₂ content. These findings support biochar-assisted P. fluorescens supplementation as a promising strategy for sustaining mungbean productivity under reduced NPK input, warranting further field validation for broader applicability.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42533028 · DOI · PMC13424373

Anti-Inflammatory and Antioxidant Strategies in Epilepsy: From Molecular Mechanisms to Threshold Management [3]

Review article Trofimov A, Shcherbakova K, Schwarz A, Akbay B, Karapina O, Myrkhiyeva Z, et al. · · 2026 · cited 1 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Epilepsy is a multifactorial disorder, yet routine management still focuses on neuronal excitation and insufficient inhibition, with antiseizure medications (ASMs) as the primary therapeutic strategy.
Closing excerpt
Together, these proposals reframe epilepsy management from sequential pharmacological trials toward coordinated optimization of the full seizure threshold landscape.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (174 words)

Epilepsy is a multifactorial disorder, yet routine management still focuses on neuronal excitation and insufficient inhibition, with antiseizure medications (ASMs) as the primary therapeutic strategy. This approach fails in roughly one-third of patients who develop drug-resistant epilepsy (DRE). Converging evidence links DRE with neuroinflammation, oxidative stress (OS), and mitochondrial dysfunction-an interconnected distal pathophysiological triad that progressively lowers seizure thresholds yet remains peripheral to clinical epilepsy management. We map this triad mechanistically and show that ASMs modulate it beyond their anticonvulsant activity, while triad-targeting pharmacological, dietary, and botanical interventions independently reduce seizure susceptibility. Common precipitants are reinterpreted as acute activators of the distal triad, linking precipitant identification and patient agency to threshold elevation. Integrating these elements, we propose a threshold management framework for DRE, built on a revised reservoir model, and translate it into three structural priorities: mechanistic phenotyping to stratify patients by pathophysiological domain, dual-mechanism drug development, and trial designs suited to multicomponent, context-dependent interventions. Together, these proposals reframe epilepsy management from sequential pharmacological trials toward coordinated optimization of the full seizure threshold landscape.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42589265 · DOI · PMC13466846

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis [4]
    Bjelakovic G, Nikolova D, Simonetti RG, Gluud C · Lancet · 2004 · cited 368 times (Europe PMC)
  • Research article Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies [5]
    Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, et al. · Am J Clin Nutr · 2018 · cited 283 times (Europe PMC)
  • Research article Dietary flavonoids and cancer risk: evidence from human population studies [6]
    Neuhouser ML · Nutr Cancer · 2004 · cited 281 times (Europe PMC)
  • Research article Higher antioxidant and lower cadmium concentrations and lower incidence of pesticide residues in organically grown crops: a systematic literature review and meta-analyses [7]
    Barański M, Srednicka-Tober D, Volakakis N, Seal C, Sanderson R, Stewart GB, et al. · Br J Nutr · 2014 · cited 227 times (Europe PMC)
  • Research article The Antioxidant Effect of Exercise: A Systematic Review and Meta-Analysis [8]
    de Sousa CV, Sales MM, Rosa TS, Lewis JE, de Andrade RV, Simões HG · Sports Med · 2017 · cited 219 times (Europe PMC)
  • Research article Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [9]
    Serban MC, Sahebkar A, Zanchetti A, Mikhailidis DP, Howard G, Antal D, et al. · J Am Heart Assoc · 2016 · cited 198 times (Europe PMC)

References

  1. Anselmo-Moreira F, Claude A, do Nascimento A, da Costa BRB, Hurtado-Caceres I, Rocco M, et al.. Drought modulates ozone stress through BVOCs, antioxidant defenses, and metabolic responses in a tropical tree. . 2026. PMID 42477286 · DOI · PMC13384984
  2. Amin M, Sani MNH, Rahman MM, Akter S, Mahabub MR, Mohsin SM, et al.. Biochar-biostimulant combinations enhance nodulation, yield, and antioxidant defense in mungbean under reduced NPK fertilization. . 2026. PMID 42533028 · DOI · PMC13424373
  3. Trofimov A, Shcherbakova K, Schwarz A, Akbay B, Karapina O, Myrkhiyeva Z, et al.. Anti-Inflammatory and Antioxidant Strategies in Epilepsy: From Molecular Mechanisms to Threshold Management. . 2026. PMID 42589265 · DOI · PMC13466846
  4. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet. 2004. PMID 15464182 · DOI
  5. Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, et al.. Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies. Am J Clin Nutr. 2018. PMID 30475962 · DOI · PMC6250988
  6. Neuhouser ML. Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer. 2004. PMID 15572291 · DOI
  7. Barański M, Srednicka-Tober D, Volakakis N, Seal C, Sanderson R, Stewart GB, et al.. Higher antioxidant and lower cadmium concentrations and lower incidence of pesticide residues in organically grown crops: a systematic literature review and meta-analyses. Br J Nutr. 2014. PMID 24968103 · DOI · PMC4141693
  8. de Sousa CV, Sales MM, Rosa TS, Lewis JE, de Andrade RV, Simões HG. The Antioxidant Effect of Exercise: A Systematic Review and Meta-Analysis. Sports Med. 2017. PMID 27260682 · DOI
  9. Serban MC, Sahebkar A, Zanchetti A, Mikhailidis DP, Howard G, Antal D, et al.. Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2016. PMID 27405810 · DOI · PMC5015358

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Cholinesterase InhibitorsPharmacology
  • Adrenergic AntagonistsPharmacology
  • Calcium Channel BlockersPharmacology
  • Cyclooxygenase InhibitorsPharmacology
  • Muscarinic AntagonistsPharmacology
  • NeurosteroidsPharmacology

All 99 articles in Pharmacology →

At a glance

206,435
PubMed records on this heading
35%
published since 2020
25,191
review articles
5,057
randomized trials
9
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Cholinesterase InhibitorsPharmacology
  • Adrenergic AntagonistsPharmacology
  • Calcium Channel BlockersPharmacology
  • Cyclooxygenase InhibitorsPharmacology
  • Muscarinic AntagonistsPharmacology

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support